| Primary |
| Hypertonic Bladder |
35.8% |
| Drug Use For Unknown Indication |
19.4% |
| Product Used For Unknown Indication |
7.9% |
| Pollakiuria |
7.3% |
| Urinary Incontinence |
5.5% |
| Incontinence |
4.8% |
| Bladder Disorder |
3.0% |
| Hypercholesterolaemia |
2.4% |
| Micturition Urgency |
2.4% |
| Multiple Sclerosis |
2.4% |
| Pain |
1.8% |
| Diabetes Mellitus |
1.2% |
| Nocturia |
1.2% |
| Urge Incontinence |
1.2% |
| Blood Cholesterol Increased |
0.6% |
| Cerebrovascular Accident |
0.6% |
| Complex Regional Pain Syndrome |
0.6% |
| Cystitis Interstitial |
0.6% |
| Depression |
0.6% |
| Dyspepsia |
0.6% |
|
| Drug Ineffective |
11.4% |
| Vision Blurred |
11.4% |
| Urinary Retention |
10.0% |
| Constipation |
7.1% |
| Pollakiuria |
7.1% |
| Headache |
5.7% |
| Dizziness |
4.3% |
| Dry Mouth |
4.3% |
| Dyspnoea |
4.3% |
| Pruritus |
4.3% |
| Urinary Incontinence |
4.3% |
| Diarrhoea |
2.9% |
| Dysuria |
2.9% |
| Grand Mal Convulsion |
2.9% |
| Hypersensitivity |
2.9% |
| Pain |
2.9% |
| Rash |
2.9% |
| Rectal Haemorrhage |
2.9% |
| Renal Failure |
2.9% |
| Temperature Intolerance |
2.9% |
|
| Secondary |
| Hypertonic Bladder |
25.5% |
| Asthma |
20.0% |
| Product Used For Unknown Indication |
9.1% |
| Chronic Obstructive Pulmonary Disease |
7.3% |
| Osteoporosis |
7.3% |
| Bladder Disorder |
5.5% |
| Blood Cholesterol Increased |
3.6% |
| Multiple Sclerosis |
3.6% |
| Pollakiuria |
3.6% |
| Atrial Fibrillation |
1.8% |
| Dementia |
1.8% |
| Dyslipidaemia |
1.8% |
| Glaucoma |
1.8% |
| Hypothyroidism |
1.8% |
| Pain |
1.8% |
| Parkinson's Disease |
1.8% |
| Urinary Incontinence |
1.8% |
|
| Vocal Cord Disorder |
18.2% |
| Drug Ineffective |
9.1% |
| Grand Mal Convulsion |
9.1% |
| Abdominal Pain |
4.5% |
| Drug Hypersensitivity |
4.5% |
| Drug Interaction |
4.5% |
| Dyspepsia |
4.5% |
| Headache |
4.5% |
| Melaena |
4.5% |
| Micturition Urgency |
4.5% |
| Myalgia |
4.5% |
| Nausea |
4.5% |
| Orthostatic Hypotension |
4.5% |
| Pneumonia Aspiration |
4.5% |
| Sleep Disorder |
4.5% |
| Tremor |
4.5% |
| Weight Decreased |
4.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.3% |
| Drug Use For Unknown Indication |
13.0% |
| Multiple Sclerosis |
11.4% |
| Osteoporosis |
5.3% |
| Hypertension |
5.1% |
| Depression |
4.4% |
| Pain |
4.1% |
| Cardiac Disorder |
3.6% |
| Constipation |
2.6% |
| Parkinson's Disease |
2.4% |
| Rheumatoid Arthritis |
2.2% |
| Blood Cholesterol Increased |
2.0% |
| Dementia |
1.8% |
| Hypertonic Bladder |
1.8% |
| Bladder Disorder |
1.7% |
| Diabetes Mellitus |
1.7% |
| Asthma |
1.6% |
| Back Pain |
1.6% |
| Prophylaxis |
1.6% |
| Urinary Incontinence |
1.6% |
|
| Vomiting |
9.9% |
| Weight Increased |
8.1% |
| Myocardial Infarction |
7.2% |
| Somnolence |
7.2% |
| Weight Decreased |
7.2% |
| Pneumonia |
5.4% |
| Urinary Tract Infection |
5.4% |
| Fatigue |
4.5% |
| Nausea |
4.5% |
| Pulmonary Embolism |
4.5% |
| Rectal Haemorrhage |
4.5% |
| Renal Disorder |
4.5% |
| Drug Ineffective |
3.6% |
| Muscle Spasms |
3.6% |
| Small Cell Lung Cancer Stage Unspecified |
3.6% |
| Swelling Face |
3.6% |
| Thrombosis |
3.6% |
| Visual Acuity Reduced |
3.6% |
| Adenocarcinoma |
2.7% |
| Confusional State |
2.7% |
|
